Using data to predict early signs of serious illness in premature infants.
Integrated physiomarker, biomarker and clinical predictive analytics for early warning of sepsis and necrotizing enterocolitis in very low birth weight infants.
This study is working on new ways to use different health information to spot early signs of serious conditions like sepsis and necrotizing enterocolitis in tiny babies who weigh very little at birth, helping doctors take action sooner to keep these little ones healthy and safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10773555 on NIH RePORTER |
What this research studies
This research focuses on developing advanced tools that combine various health data to detect early signs of sepsis and necrotizing enterocolitis in very low birth weight infants. By integrating physiomarkers, biomarkers, and clinical risk markers, the goal is to create predictive analytics that can alert healthcare providers to potential health issues before they become critical. This approach aims to improve early diagnosis and treatment, ultimately enhancing the survival and health outcomes of these vulnerable infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are very low birth weight infants, particularly those born prematurely who are at high risk for sepsis and necrotizing enterocolitis.
Not a fit: Patients who are not very low birth weight infants or those who are not born prematurely may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of life-threatening conditions in premature infants, significantly improving their chances of survival and long-term health.
How similar studies have performed: Other research has shown promise in using predictive analytics for early diagnosis in neonatal care, indicating that this approach could be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Sullivan, Brynne Archer — University of Virginia
- Study coordinator: Sullivan, Brynne Archer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.